Advertisement
Screener

Tevogen Inc. (TVGN) Graph

TVGN Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2021-06-30: Net income -$11.30K.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 2 month

Period endNet income
2021-06-30-$11.30K

Revenue and expense 3 month

Period endResearch and developmentOperating expensesNet income
2026-06-30$3.28M$5.66M-$5.76M
2026-03-31$3.13M$5.40M-$5.45M
2025-12-31$2.11M*$4.61M*-$4.68M*
2025-09-30$3.11M$5.73M-$5.73M
2025-06-30$2.70M$5.44M-$5.50M
2025-03-31$3.20M$10.36M-$10.37M
2024-09-30$3.26M$6.09M-$5.88M
2024-06-30$4.12M$8.60M-$9.66M
2024-03-31$20.81M$29.52M$11.26M
2023-09-30$1.12M$2.33M-$3.90M
2023-06-30$1.03M$2.18M-$22.18M
2023-03-31$1.35M(m)-$30.76M
2022-09-30(m)$198.83K$1.61M
2022-06-30(m)(m)$207.00K
2022-03-31(m)(m)-$25.99K
2021-09-30(m)$115.00-$115.00

Revenue and expense 5 month

Period endOperating expensesNet income
2021-09-30$11.41K-$11.41K

Revenue and expense 6 month

Period endResearch and developmentOperating expensesNet income
2026-06-30$6.42M$11.06M-$11.21M
2025-06-30$5.90M$15.80M-$15.87M
2024-06-30$24.94M$38.12M$1.60M
2023-06-30$2.38M$4.51M-$52.94M
2022-06-30(m)(m)$181.01K

Revenue and expense 8 month

Period endNet income
2021-12-31(m)

Revenue and expense 9 month

Period endResearch and developmentOperating expensesNet income
2025-09-30$9.01M$21.53M-$21.60M
2024-09-30$28.20M$44.20M-$4.28M
2023-09-30$3.50M$6.83M-$56.85M
2022-09-30(m)$740.30K$1.79M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$11.11M$26.14M$4.75K-$26.28M
2024-12-31$31.03M$53.56M$1.75K-$13.73M
2023-12-31$4.40M$8.84M(m)-$60.48M
2022-12-31(m)(m)(m)$4.41M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Scilex Holding Co (SCLX)United States$0.042B-0.14
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B